Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Bacitracin- and neomycin- and polymyxin B- and pramocaine-containing product |
Is a |
Bacitracin-containing product |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Bacitracin- and neomycin- and polymyxin B- and pramocaine-containing product |
Is a |
Pramoxine (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Bacitracin- and neomycin- and polymyxin B- and pramocaine-containing product |
Is a |
Neomycin-containing product |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Bacitracin- and neomycin- and polymyxin B- and pramocaine-containing product |
Is a |
Product containing polymyxin B (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Bacitracin- and neomycin- and polymyxin B- and pramocaine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Bacitracin |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
4 |
|
Bacitracin- and neomycin- and polymyxin B- and pramocaine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Pramocaine (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
|
Bacitracin- and neomycin- and polymyxin B- and pramocaine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Neomycin |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Bacitracin- and neomycin- and polymyxin B- and pramocaine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Polymyxin B |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Bacitracin- and neomycin- and polymyxin B- and pramocaine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
anti-infectieux cutané |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Bacitracin- and neomycin- and polymyxin B- and pramocaine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Bactericide |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Bacitracin- and neomycin- and polymyxin B- and pramocaine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Local anti-infective |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Bacitracin- and neomycin- and polymyxin B- and pramocaine-containing product |
Is a |
Topical neomycin |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Bacitracin- and neomycin- and polymyxin B- and pramocaine-containing product |
Is a |
Product containing bacitracin in topical dosage form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Bacitracin- and neomycin- and polymyxin B- and pramocaine-containing product |
Has manufactured dose form |
forme pharmaceutique pour usage transdermique et/ou cutané |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Bacitracin- and neomycin- and polymyxin B- and pramocaine-containing product |
Is a |
Product containing neomycin and polymyxin B (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Bacitracin- and neomycin- and polymyxin B- and pramocaine-containing product |
Is a |
Product containing neomycin and polymyxin B and pramocaine (medicinal product) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Bacitracin- and neomycin- and polymyxin B- and pramocaine-containing product |
Is a |
Product containing bacitracin and polymyxin B (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Bacitracin- and neomycin- and polymyxin B- and pramocaine-containing product |
Is a |
Product containing bacitracin and neomycin and polymyxin B (medicinal product) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Bacitracin- and neomycin- and polymyxin B- and pramocaine-containing product |
Plays role |
Antibacterial therapeutic role (role) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|